10:27 IST
NSE
Adverse Business Impact
Zydus Lifesciences Adverse Business Impact
Zydus Lifesciences received a USFDA Warning Letter regarding its Baddi facility's purified talc technical observations. The company expects no impact on current operations or supplies.